» Articles » PMID: 24298056

VHL-mediated Disruption of Sox9 Activity Compromises β-cell Identity and Results in Diabetes Mellitus

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2013 Dec 4
PMID 24298056
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Precise functioning of the pancreatic β cell is paramount to whole-body glucose homeostasis, and β-cell dysfunction contributes significantly to diabetes mellitus. Using transgenic mouse models, we demonstrate that deletion of the von Hippel-Lindau (Vhlh) gene (encoding an E3 ubiquitin ligase implicated in, among other functions, oxygen sensing in pancreatic β cells) is deleterious to canonical β-cell gene expression. This triggers erroneous expression of factors normally active in progenitor cells, including effectors of the Notch, Wnt, and Hedgehog signaling cascades. Significantly, an up-regulation of the transcription factor Sox9, normally excluded from functional β cells, occurs upon deletion of Vhlh. Sox9 plays important roles during pancreas development but does not have a described role in the adult β cell. β-Cell-specific ectopic expression of Sox9 results in diabetes mellitus from similar perturbations in β-cell identity. These findings reveal that assaults on the β cell that impact the differentiation state of the cell have clear implications toward our understanding of diabetes mellitus.

Citing Articles

The MODY-associated L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults.

Nakhe A, Dadi P, Kim J, Dickerson M, Behera S, Dobson J Elife. 2024; 12.

PMID: 38700926 PMC: 11068355. DOI: 10.7554/eLife.89967.


Sox9 regulates alternative splicing and pancreatic beta cell function.

Puri S, Maachi H, Nair G, Russ H, Chen R, Pulimeno P Nat Commun. 2024; 15(1):588.

PMID: 38238288 PMC: 10796970. DOI: 10.1038/s41467-023-44384-8.


Cross-regulation between SOX9 and the canonical Wnt signalling pathway in stem cells.

Wang J, Wan X, Le Q Front Mol Biosci. 2023; 10:1250530.

PMID: 37664185 PMC: 10469848. DOI: 10.3389/fmolb.2023.1250530.


Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant.

Shilleh A, Russ H Cells. 2023; 12(5).

PMID: 36899834 PMC: 10000642. DOI: 10.3390/cells12050698.


Retinal hemangioblastoma in a patient with Von Hippel-Lindau disease: A case report and literature review.

Huang Y, Hu W, Huang X Front Oncol. 2022; 12:963469.

PMID: 36408156 PMC: 9667117. DOI: 10.3389/fonc.2022.963469.


References
1.
Sakata N, Chan N, Ostrowski R, Chrisler J, Hayes P, Kim S . Hyperbaric oxygen therapy improves early posttransplant islet function. Pediatr Diabetes. 2010; 11(7):471-8. PMC: 2914840. DOI: 10.1111/j.1399-5448.2009.00629.x. View

2.
Li X, Zhang L, Meshinchi S, Dias-Leme C, Raffin D, Johnson J . Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes. 2006; 55(11):2965-73. DOI: 10.2337/db06-0733. View

3.
Carlson M, Silva H, Conboy I . Aging of signal transduction pathways, and pathology. Exp Cell Res. 2008; 314(9):1951-61. PMC: 2572856. DOI: 10.1016/j.yexcr.2008.03.017. View

4.
Cano D, Sekine S, Hebrok M . Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology. 2006; 131(6):1856-69. DOI: 10.1053/j.gastro.2006.10.050. View

5.
Rausa F, Samadani U, Ye H, Lim L, Fletcher C, Jenkins N . The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas. Dev Biol. 1998; 192(2):228-46. DOI: 10.1006/dbio.1997.8744. View